Comparing of Different Biomarkers From Vena Rectalis Superior and Vena Cubiti in Patients Undergoing Low Anterior Resection for Rectum Cancer
Recruitment status was: Recruiting
|Rectal Cancer||Other: blood sampels from vena rectalis superior and vena cubiti|
|Study Design:||Observational Model: Case Control
Time Perspective: Prospective
- The primary aim of the present study is to investigate different biomarkers like VEGF, EVGF and others ability to predict time to recidive and progressions free survival. [ Time Frame: after the study is complete ]
|Study Start Date:||September 2011|
|Estimated Study Completion Date:||December 2015|
|Estimated Primary Completion Date:||September 2015 (Final data collection date for primary outcome measure)|
|Biomarkeres||Other: blood sampels from vena rectalis superior and vena cubiti|
Patients undergoing LAR for rectum cancer is subjected. Preoperative blood samples from vena rectalis superior and vena cubiti is collected, as well as biopsies from tumor. Preoperative and after 3 month peripheral blood samples is collected.
A total of 50 patients will be included in this study.
The study is approved by the local scientific ethical committee No. S-20100006
Please refer to this study by its ClinicalTrials.gov identifier: NCT01706809
|Vejle, Denmark, 5000|
|Contact: Hans Rahr, MD 7940 5600 ext 0045 firstname.lastname@example.org|